Organigram Global (OGI) Return on Assets (2019 - 2026)

Organigram Global (OGI) posted quarterly Return on Assets of 0.0% for Q1 2026, up 69.16% quarter-over-quarter from 0.0% in Q4 2025.

Organigram Global (OGI) Return on Assets (2019 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Return on Assets for 5 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

In Q1 2026, Return on Assets changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
Return on Assets climbed to 0.0% in Q1 2026 per OGI's latest filing, from 0.0% in the prior quarter.
Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Haleon	44.00 Bn	43.04 Bn	-	0.00%
2	Teva Pharmaceutical Industries	43.30 Bn	39.65 Bn	2.15 Bn	0.00%
3	Zoetis	31.78 Bn	30.10 Bn	1.05 Bn	0.00%
4	Takeda Pharmaceutical	28.71 Bn	22.92 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.21 Bn	19.54 Bn	683.80 Mn	0.00%
6	Viatris	18.77 Bn	17.88 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.60 Bn	15.21 Bn	935.80 Mn	0.00%
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	0.00%
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	0.00%
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn	0.00%

Download Data